Caisse de Depot et Placement du Quebec (CDPQ)
TEVA icon

Caisse de Depot et Placement du Quebec (CDPQ)’s Teva Pharmaceuticals TEVA Stock Holding History

Caisse de Depot et Placement du Quebec (CDPQ)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-545,310
Closed -$7.69M – 539
2024
Q1 		$7.69M Buy
+545,310
New +$6.87M 0.02% 334
2023
Q2 		– Sell
-556,703
Closed -$4.93M – 544
2023
Q1 		$4.93M Sell
556,703
-7,625
-1% -$75.4K 0.01% 391
2022
Q4 		$5.15M Buy
564,328
+207,117
+58% +$1.81M 0.02% 401
2022
Q3 		$2.88M Sell
357,211
-331,400
-48% -$2.93M 0.01% 418
2022
Q2 		$5.18M Sell
688,611
-225,200
-25% -$1.96M 0.01% 363
2022
Q1 		$8.58M Buy
913,811
+198,000
+28% +$1.65M 0.02% 373
2021
Q4 		$5.73M Sell
715,811
-267,721
-27% -$2.42M 0.01% 381
2021
Q3 		$9.58M Buy
983,532
+819,029
+498% +$7.67M 0.02% 313
2021
Q2 		$1.63M Sell
164,503
-3,063,239
-95% -$32.4M ﹤0.01% 425
2021
Q1 		$37.2M Buy
3,227,742
+2,662,358
+471% +$30.5M 0.08% 127
2020
Q4 		$5.46M Sell
565,384
-271,744
-32% -$2.6M 0.01% 281
2020
Q3 		$7.54M Sell
837,128
-45,700
-5% -$483K 0.02% 205
2020
Q2 		$10.9M Sell
882,828
-421,341
-32% -$4.77M 0.03% 173
2020
Q1 		$11.7M Buy
1,304,169
+368,941
+39% +$3.78M 0.04% 179
2019
Q4 		$9.16M Sell
935,228
-491,133
-34% -$4.38M 0.02% 230
2019
Q3 		$9.81M Buy
1,426,361
+610,440
+75% +$4.68M 0.02% 235
2019
Q2 		$7.53M Buy
815,921
+8,235
+1% +$99.3K 0.02% 255
2019
Q1 		$12.7M Buy
807,686
+48,058
+6% +$847K 0.03% 208
2018
Q4 		$11.7M Sell
759,628
-3,362,200
-82% -$68.9M 0.03% 211
2018
Q3 		$88.8M Buy
4,121,828
+1,767,320
+75% +$41M 0.21% 91
2018
Q2 		$57.3M Buy
2,354,508
+1,264,900
+116% +$25.8M 0.14% 108
2018
Q1 		$18.6M Buy
1,089,608
+761,380
+232% +$14.9M 0.05% 185
2017
Q4 		$6.22M Buy
328,228
+307,700
+1,499% +$4.63M 0.01% 330
2017
Q3 		$363K Sell
20,528
-260,600
-93% -$5.86M ﹤0.01% 699
2017
Q2 		$9.31M Sell
281,128
-257,600
-48% -$7.97M 0.02% 242
2017
Q1 		$17.3M Buy
538,728
+103,300
+24% +$3.53M 0.04% 181
2016
Q4 		$15.8M Buy
+435,428
New +$17.4M 0.04% 184
2015
Q3 		– Sell
-116,700
Closed -$6.9M – 697
2015
Q2 		$6.9M Hold
116,700
– – 0.02% 358
2015
Q1 		$7.27M Hold
116,700
– – 0.02% 359
2014
Q4 		$6.71M Buy
+116,700
New +$6.5M 0.02% 377

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Caisse de Depot et Placement du Quebec (CDPQ)'s TEVA Position: Q2 2024 in Review

Caisse de Depot et Placement du Quebec (CDPQ) sold out of Teva Pharmaceuticals (TEVA) in Q2 2024, closing a stake of 545,310 shares — an estimated $7.69M sold.

Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in TEVA in Q4 2014 and held it in 30 quarters. The position peaked at $88.8M in Q3 2018. 533 funds tracked by Wall St. Rank hold TEVA as of Q2 2024.

  • Caisse de Depot et Placement du Quebec (CDPQ) reported no remaining Teva Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Caisse de Depot et Placement du Quebec (CDPQ) sold 545,310 Teva Pharmaceuticals shares in Q2 2024, an estimated $7.69M.
  • Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in Teva Pharmaceuticals in Q4 2014 and held it in 30 quarters.
  • Caisse de Depot et Placement du Quebec (CDPQ)'s Teva Pharmaceuticals position peaked at $88.8M in Q3 2018.
  • 533 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2024.

Based on Caisse de Depot et Placement du Quebec (CDPQ)'s 13F filing for Q2 2024, filed 14 Aug 2024.